{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:43:00Z","timestamp":1792312980581,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1097\/01.coc.0000217829.77404.22","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T14:55:51Z","timestamp":1149087351000},"page":"240-245","source":"Crossref","is-referenced-by-count":16,"title":["Concurrent Chemoradiotherapy With Doxifluridine and Paclitaxel for Extrahepatic Bile Duct Cancer"],"prefix":"10.1097","volume":"29","author":[{"given":"Jeong Youp","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Bock","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsil","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210509","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1096-9098(199708)65:4<298::AID-JSO12>3.0.CO;2-Z","article-title":"Biliary tree malignancies: the university of Minnesota experience.","volume":"65","author":"Lee","year":"1997","journal-title":"J Surg Oncol"},{"key":"R2-5-20210509","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000658-199201000-00005","article-title":"Management strategies in resection for hilar cholangiocarcinoma.","volume":"215","author":"Bismuth","year":"1992","journal-title":"Ann Surg"},{"key":"R3-5-20210509","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00000658-199611000-00007","article-title":"Surgical treatment in proximal bile duct cancer.","volume":"224","author":"Pichlmayr","year":"1996","journal-title":"Ann Surg"},{"key":"R4-5-20210509","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma a spectrum of intrahepatic, perihilar, and distal tumors.","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"R5-5-20210509","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2321::AID-CNCR4>3.0.CO;2-V","article-title":"A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.","volume":"82","author":"Sanz-Atamira","year":"1998","journal-title":"Cancer"},{"key":"R6-5-20210509","first-page":"2020","article-title":"Prospective randomized trial of 5-fluorouracil, doxorubicin and mitomycin c for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.","volume":"45","author":"Takada","year":"1998","journal-title":"Hepato Gastroenterol"},{"key":"R7-5-20210509","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gut.39.6.852","article-title":"A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.","volume":"39","author":"Bowling","year":"1996","journal-title":"Gut"},{"key":"R8-5-20210509","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","article-title":"Perihilar cholangiocarcinoma postoperative radiotherapy does not improve survival.","volume":"221","author":"Pitt","year":"1995","journal-title":"Ann Surg"},{"key":"R9-5-20210509","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0360-3016(99)00487-3","article-title":"Combined modality treatment in unresectable extrahepatic biliary carcinoma.","volume":"46","author":"Morganti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-5-20210509","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.510310205","article-title":"Photodynamic therapy for advanced bile duct cancer: evidence for improved palliations and extended survival.","volume":"31","author":"Berr","year":"2000","journal-title":"Hepatology"},{"key":"R11-5-20210509","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1995.13.1.227","article-title":"Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreatobiliary carcinoma: a phase I Eastern Cooperation Oncology Group trial.","volume":"13","author":"Whittington","year":"1995","journal-title":"J Clin Oncol"},{"key":"R12-5-20210509","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/cncr.20265","article-title":"Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.","volume":"100","author":"Shunro","year":"2004","journal-title":"Cancer"},{"key":"R13-5-20210509","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1248\/cpb.31.175","article-title":"Activation of 5\u2032-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.","volume":"31","author":"Kono","year":"1983","journal-title":"Chem Pharm Bull"},{"key":"R14-5-20210509","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Response of pancreatic cancer to locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil.","volume":"48","author":"Moertel","year":"1981","journal-title":"Cancer"},{"key":"R15-5-20210509","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/1097-0142(19930601)71:11<3774::AID-CNCR2820711147>3.0.CO;2-0","article-title":"Investigation of taxol as a potential radiation sensitizer.","volume":"71","author":"Choy","year":"1993","journal-title":"Cancer"},{"key":"R16-5-20210509","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(98)00509-4","article-title":"Radiotherapy and multimodality management of cholangiocarcinoma.","volume":"44","author":"Urego","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-5-20210509","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/annonc\/10.suppl_4.S239","article-title":"Surgical possibilities for bile duct cancer: standard surgical treatment.","volume":"10","author":"Benjamin","year":"1999","journal-title":"Ann Oncol"},{"key":"R18-5-20210509","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ijrobp.2004.05.061","article-title":"A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer.","volume":"60","author":"Chung","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-5-20210509","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0016-5107(88)71271-7","article-title":"Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internalbiliary drainage.","volume":"2","author":"Devie\u2032re","year":"1988","journal-title":"Gastrointest Endosc"},{"key":"R20-5-20210509","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.721","article-title":"Sample size tables for exact single-stage phase II designs.","volume":"20","author":"A'Hern","year":"2001","journal-title":"Statist Med"},{"key":"R21-5-20210509","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9610(97)00203-1","article-title":"Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.","volume":"174","author":"McMasters","year":"1997","journal-title":"Am J Surg"},{"key":"R22-5-20210509","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-2964(80)90221-2","article-title":"Tumor inhibitory effects of a new fluorouracil derivative: 5-deoxy-5-fluorouridine.","volume":"16","author":"Bollag","year":"1980","journal-title":"Eur J Cancer"},{"key":"R23-5-20210509","first-page":"2213","article-title":"Paclitaxel and radiotherapy: sequence-dependent efficacy-a preclinical model.","volume":"5","author":"Niero","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R24-5-20210509","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.1996.14.8.2306","article-title":"Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.","volume":"14","author":"Jones","year":"1996","journal-title":"J Clin Oncol"},{"key":"R25-5-20210509","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0360-3016(95)02132-9","article-title":"The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and\/or external beam radiotherapy.","volume":"34","author":"Kamada","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-5-20210509","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1200\/JCO.2001.19.7.1961","article-title":"Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.","volume":"19","author":"Kies","year":"2001","journal-title":"J Clin Oncol"},{"key":"R27-5-20210509","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00000421-200102000-00018","article-title":"Pilot study of concurrent 5-fluorouracil\/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction.","volume":"24","author":"Schnirer","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"R28-5-20210509","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00000658-198110000-00008","article-title":"Prognostic factors in bile duct carcinoma.","volume":"194","author":"Tompkins","year":"1981","journal-title":"Ann Surg"},{"key":"R29-5-20210509","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00000658-199604000-00007","article-title":"Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.","volume":"223","author":"Su","year":"1996","journal-title":"Ann Surg"},{"key":"R30-5-20210509","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0360-3016(81)90118-8","article-title":"Patterns of failure after curative surgery for extraheaptic biliary tract carcinoma: implications for adjuvant therapy.","volume":"7","author":"Kopelson","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-200606000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T09:19:29Z","timestamp":1620638369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200606000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000217829.77404.22","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}